|
 |
| home > pmps > winter 2003 > new developments in the containment of pharmaceutical powders |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
There is a growing trend for routine day-to-day pharmaceutical powder processing and production operations to involve 'high potency' powders. To meet this challenge new strategies for powder handling are being developed along with engineering advances in the equipment used to contain the active or high potency materials. The term 'containment', of course, refers to the isolation of hazardous materials (high potency) using engineering methods in various guises. Containment can protect the operator from the compound or protect the compound from operator-borne containment. In some cases specialised containment devices protect the operator from the materials and vice versa.
First of all it is important to appreciate the growth of high potency compounds within the pharmaceutical industry. In 1990, only about five per cent of all pharmaceutical actives handled were considered potent. Now in the year 2001, over 30 per cent of all APIs are classified as 'potent', and therefore require special attention to protect the operator from the effects of coming into contact with these materials.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Martyn Ryder, Director of Extract Technology, part of the Carlisle Sciences Group
Martyn Ryder, Vice President of Business Development at Carlisle Life Sciences Europe, was educated at Leeds Polytechnic in HVAC and Building Services. In 1981 he founded Extract Technology, a company which has grown to be one of the world's leading suppliers of pharmaceutical dust control and high containment systems. The company is now part of the Carlisle Life Sciences Group, a division of Carlisle Corporation, a diversified global manufacturing company, serving the transportation, construction, commercial roofing, automotive, food service, data transmission and pharmaceutical and biotech industries.
|
|
|
|
|
|
 |
Industry Events |
 |
Small Scale Biomanufacturing – clinical trials, cell & gene therapies
18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol
This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >> |
|
 |
News and Press Releases |
 |
Ultra slim and ultra quick
More info >>
|
|
 |
